Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Taiyen Biotech CoTPE:1737 -0.31%84 5-Year Yield-on-Cost % is 3.49 as of Aug. 06, 2026, which is 8% below its 10-year median of 3.80. GuruFocus rates TPE:1737 with a GF Score™ of 84/100 and a GF Value™ of NT$31.81 (Fairly Valued). The stock has 1 warning sign investors should review. Among 1,167 Consumer Packaged Goods companies, Taiyen Biotech Co ranks better than 50.47% on this metric.
Taiyen Biotech Co's yield on cost for the quarter that ended in Mar. 2026 was 3.49.
The historical rank and industry rank for Taiyen Biotech Co's 5-Year Yield-on-Cost % or its related term are showing as below:
TPE:1737'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.8 Med: 3.8 Max: 8.14
Current: 3.49
During the past 13 years, Taiyen Biotech Co's highest Yield on Cost was 8.14. The lowest was 2.80. And the median was 3.80.
TPE:1737's 5-Year Yield-on-Cost % is ranked better than 50.47% of 1167
companies
in the Consumer Packaged Goods industry
Industry Median: 3.41
vs TPE:1737: 3.49
Taiyen Biotech Co (TPE:1737) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Taiyen Biotech Co 5-Year Yield-on-Cost % Related Terms
TPE:1737 vs PG, CL, KVUE: 5-Year Yield-on-Cost % Comparison
For the Household & Personal Products subindustry, Taiyen Biotech Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiyen Biotech Co 5-Year Yield-on-Cost % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Taiyen Biotech Co's 5-Year Yield-on-Cost % falls into.
Taiyen Biotech Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Taiyen Biotech Co (TPE:1737) has a 5-Year Yield-on-Cost % of 3.49 as of Aug. 06, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Taiyen Biotech Co and its competitors. This is near median its historical median of 3.80. Over the past decade, Taiyen Biotech Co's 5-Year Yield-on-Cost % has ranged from 2.80 to 8.14. According to the industry distribution chart, Taiyen Biotech Co ranks #578 out of 1167 companies in the Consumer Packaged Goods industry, placing it in the top 49.5%.
Is Taiyen Biotech Co's 5-Year Yield-on-Cost % too high?
Taiyen Biotech Co's current 5-Year Yield-on-Cost % of 3.49 is near median its 10-year median of 3.80. Over the past 10 years, this metric has ranged from a low of 2.80 to a high of 8.14. The Consumer Packaged Goods industry median 5-Year Yield-on-Cost % is 3.41. Taiyen Biotech Co's value of 3.49 is 2.3% above this industry median. Based on the distribution chart, Taiyen Biotech Co ranks #578 out of 1167 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Taiyen Biotech Co has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's 5-Year Yield-on-Cost % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Taiyen Biotech Co ranks #578 out of 1167 companies for 5-Year Yield-on-Cost %. This puts Taiyen Biotech Co in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 3.41. Taiyen Biotech Co's value of 3.49 is 2.3% above this benchmark. Historically, Taiyen Biotech Co's own 5-Year Yield-on-Cost % has ranged from 2.80 to 8.14 over the past decade. While the company's 10-year median is 3.80 vs. the industry median of 3.41, Taiyen Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Consumer Packaged Goods company?
The median 5-Year Yield-on-Cost % among Consumer Packaged Goods companies is 3.41, based on 1,167 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Taiyen Biotech Co's current 5-Year Yield-on-Cost % of 3.49 is 2.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Taiyen Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median 5-Year Yield-on-Cost % is 3.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiyen Biotech Co's current 5-Year Yield-on-Cost % is 3.49, which is near median its own 10-year median of 3.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$31.81, compared to a current price of NT$31.95 — trading 0.4% above its estimated fair value. The current 5-Year Yield-on-Cost % is 3.49, which is near median its 10-year median of 3.80 and 2.3% above the Consumer Packaged Goods industry median of 3.41. Taiyen Biotech Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current 5-Year Yield-on-Cost % is 3.49 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?
Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be overvalued.
The current stock price of NT$31.95 is trading 0.4% above its estimated GF Value™ of NT$31.81.
GuruFocus considers Taiyen Biotech Co to be Fairly Valued.
Key valuation signals for TPE:1737:
5-Year Yield-on-Cost %: 3.49 (near median its 10-year median of 3.80)
GF Value™: NT$31.81 vs. price of NT$31.95 (0.4% above fair value)
Industry Position: 2.3% above the Consumer Packaged Goods median (#578 of 1167)
No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
84GF Score
Get the complete analysis for TPE:1737
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1737 has been successfully added to your 
